Frontier Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Frontier Investment Management's BMY Position: Q2 2020 in Review
Frontier Investment Management increased its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2020, buying an estimated $79.3K and bringing the position to 9,046 shares worth $532K. The position accounts for 0.03% of the portfolio, ranked #151.
Frontier Investment Management first reported a position in BMY in Q1 2020 and has held it in 2 quarters since. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.
- Frontier Investment Management held 9,046 shares of Bristol-Myers Squibb worth $532K as of Q2 2020.
- Frontier Investment Management bought 1,326 Bristol-Myers Squibb shares in Q2 2020, an estimated $79.3K.
- Bristol-Myers Squibb made up 0.03% of Frontier Investment Management's portfolio in Q2 2020, its #151 holding.
- Frontier Investment Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 2 quarters since.
- 2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.
Based on Frontier Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.